Literature DB >> 8105314

Metachronous multifocal development of urothelial cancers by intraluminal seeding.

T Habuchi1, R Takahashi, H Yamada, Y Kakehi, T Sugiyama, O Yoshida.   

Abstract

To investigate the clonal origin of multifocal urothelial tumours, we analysed the p53 tumour-suppressor gene in 3 cases with bladder tumours developing after treatment for a renal pelvic or ureteral tumour and in 1 case with a ureteral tumour after treatment for a bladder tumour. For each case, identical p53 gene mutations were detected in all primary and recurrent tumours. The results suggest that heterotopic recurrence by intraluminal seeding from the original tumour is common in urothelial cancer. The data also support the view that multifocal urothelial tumours are derived from a single progenitor cell.

Entities:  

Mesh:

Year:  1993        PMID: 8105314     DOI: 10.1016/0140-6736(93)92066-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  42 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Samer El-Halwagy
Journal:  Turk J Urol       Date:  2018-03-06

3.  Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.

Authors:  Xiaheng Deng; Xiao Yang; Yidong Cheng; Xuzhong Liu; Bian Wu; Zijie Wang; Zhengkai Huang; Kang Liu; Ruizhe Zhao; Jun Wang; Qiang Lu; Chao Qin; Changjun Yin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.

Authors:  David R Yates; James W F Catto
Journal:  World J Urol       Date:  2012-09-18       Impact factor: 4.226

5.  Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Authors:  Ryo Yamashita; Reiko Watanabe; Ichiro Ito; Hideo Shinsaka; Masafumi Nakamura; Masato Matsuzaki; Masashi Niwakawa
Journal:  Int Urol Nephrol       Date:  2017-01-11       Impact factor: 2.370

6.  Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center.

Authors:  Dong Fang; Lei Zhang; Xuesong Li; Gengyan Xiong; Xiaopeng Chen; Wenke Han; Zhisong He; Liqun Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-28       Impact factor: 4.553

7.  Predictive value of gene methylation for second recurrence following surgical treatment of first bladder recurrence of a primary upper-tract urothelial carcinoma.

Authors:  Bao Guan; Yunchao Xing; Gengyan Xiong; Zhenpeng Cao; Dong Fang; Yifan Li; Yonghao Zhan; Ding Peng; Libo Liu; Xuesong Li; Liqun Zhou
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

8.  Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Authors:  Yasuyuki Kobayashi; Takashi Saika; Yoshiyuki Miyaji; Michinao Saegusa; Ryoji Arata; Naoki Akebi; Tadasu Takenaka; Daisuke Manabe; Yasutomo Nasu; Hiromi Kumon
Journal:  World J Urol       Date:  2011-07-30       Impact factor: 4.226

9.  Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.

Authors:  François Audenet; Sumit Isharwal; Eugene K Cha; Mark T A Donoghue; Esther N Drill; Irina Ostrovnaya; Eugene J Pietzak; John P Sfakianos; Aditya Bagrodia; Paari Murugan; Guido Dalbagni; Timothy F Donahue; Jonathan E Rosenberg; Dean F Bajorin; Maria E Arcila; Jaclyn F Hechtman; Michael F Berger; Barry S Taylor; Hikmat Al-Ahmadie; Gopa Iyer; Bernard H Bochner; Jonathan A Coleman; David B Solit
Journal:  Clin Cancer Res       Date:  2018-10-23       Impact factor: 12.531

10.  UroVysion® predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study.

Authors:  Hidehiro Iwata; Naoto Sassa; Masashi Kato; Yota Murase; Shuko Seko; Hideji Kawanishi; Ryohei Hattori; Momokazu Gotoh; Toyonori Tsuzuki
Journal:  Int J Clin Oncol       Date:  2020-09-21       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.